Compare XNCR & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XNCR | RPD |
|---|---|---|
| Founded | 1997 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2013 | 2015 |
| Metric | XNCR | RPD |
|---|---|---|
| Price | $15.28 | $15.37 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 21 |
| Target Price | $22.78 | ★ $24.00 |
| AVG Volume (30 Days) | 761.7K | ★ 1.1M |
| Earning Date | 11-05-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.35 |
| Revenue | $150,132,000.00 | ★ $858,667,000.00 |
| Revenue This Year | $18.81 | $2.62 |
| Revenue Next Year | N/A | $1.49 |
| P/E Ratio | ★ N/A | $44.24 |
| Revenue Growth | ★ 38.16 | 3.08 |
| 52 Week Low | $6.92 | $13.21 |
| 52 Week High | $24.91 | $41.38 |
| Indicator | XNCR | RPD |
|---|---|---|
| Relative Strength Index (RSI) | 44.33 | 43.64 |
| Support Level | $14.97 | $15.06 |
| Resistance Level | $16.17 | $15.90 |
| Average True Range (ATR) | 0.77 | 0.46 |
| MACD | -0.28 | -0.03 |
| Stochastic Oscillator | 10.81 | 15.93 |
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.